Characterization and Stability Study of Itraconazole-Loaded Microemulsions for Skin Application
Keywords:
Itraconazole, Microemulsion, Antifungal drug, StabilityAbstract
Dermatophytosis is a common disease in tropical regions and it can be treated with antifungal drugs via oral and topical administration. Topical liquid dosage form of an antifungal drug provides advantages such as reducing systemic adverse reactions, spreading on the applied area thoroughly, and convenience for patient using. This study aimed to investigate the microemulsion systems for preparing itraconazole-loaded microemulsions for topical usage. Microemulsion formation of systems consisting of different types of oil phase, aqueous phase, and surfactant was studied by titration method. Blank microemulsions were selected from the phase diagram with large microemulsion region for incorporation with itraconazole 1% w/w. The obtained formulations were observed and compared the present appearances with their blank counterparts. Stability of the formulations after being stored in light-protected glass containers at ambient temperature (28±2°C) for 8 weeks was evaluated. The drug content was quantitatively analyzed using UV-visible spectroscopy. The results showed that among 12 systems with various excipients, the optimized system was composed of 3:1 clove oil:oleic acid as oil phase, 1:1 water:propylene glycol as aqueous phase, and Tween 80 as surfactant. Incorporation of the active drug into the four selected blank microemulsions did not affect on appearances and microemulsion type. Viscosity and pH values of all prepared formulations were determined in acceptable criteria for skin application. However, low chemical stability was found when all formulations were kept under the investigated condition. Therefore, in the further study, the formulations should be improved to enhance chemical stability of the active drug.
References
Luplertlop N, Suwanmanee S. Dermatophytosis: from bench to bedside. J Trop Med Parasitol. 2013;36(2):75-87.
National Center for Biotechnology Information. PubChem Compound Summary for CID 55283, Itraconazole. [cited 2023 Nov 28]. Available from: https://pubchem.ncbi. nlm.nih.gov/compound/Itraconazole.
Souto EB, Doktorovova S, Boonme P. Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations. J Drug Deliv Sci Technol. 2011;21(1):43-54.
Lopes LB. Overcoming the cutaneous barrier with microemulsions. Pharmaceutics. 2014;6:52-77.
Boonme P, Kaewbanjong J, Amnuaikit T, Andreani T, Silva AM, Souto EB. Microemulsion and microemulsion-based gels for topical antifungal therapy with phytochemicals. Curr Pharm Des. 2016;22(27):4257-4263.
Boonme P, Wuttikul K, Fookloy K, Promjan S, Teeranachaideekul V. Formulation development and characterization of topical itraconazole microemulsion-organogels. Lat Am J Pharm. 2017;36(5):896-901.
Patel TB, Patel TR, Suhagia BN. Preparation, characterization, and optimization of microemulsion for topical delivery of itraconazole. J Drug Deliv Ther. 2018;8(2):136-145.
Public Health England. Methanol: Toxicological Overview. [cited 2023 Nov 28]. Available from: https://assets.publishing.service.gov.uk/media/5a7f16d6e5274a2e8ab4a0be/Methanol_TO_PHE_260815.pdf.
Promjan S, Boonme P. Itraconazole-loaded micro-emulsions: formulation, characterization, and dermal delivery using shed snakeskin as the model membrane. Pharm Dev Technol. 2023;28(1):51-60.
ณัฐธิดา ภัคพยัต, ทรงวุฒิ ยศวิมลวัฒน์, ประภาพร บุญมี. กรีน- ไมโครอิมัลชันสำหรับเครื่องสำอาง. วารสารไทยเภสัชศาสตร์และวิทยาการสุขภาพ 2554;6(4):290-298.
Lou H, Qiu N, Crill C, Helms R, Almoazen H. Development of w/o microemulsion for transdermal delivery of iodide ions. AAPS PharmSciTech. 2013;14(1): 168-176.
Wuttikul K, Boonme P. N-acetylglucosamine micro-emulsions: assessment of physicochemical stability and in vitro release. Lat Am J Pharm. 2019;38(9):1823-1830.
Srinivas L, Hemalatha B, Vinai KT, Naga MRB, Bhanu TB. Studies on solubility and dissolution enhancement of itraconazole by complexation with sulfo-butyl7 ether cyclodextrin. Asian J Biomed Pharm Sci. 2014;4(38):6-16.
Mehta SK, Kaur G, Bhasin KK. Tween-embedded microemulsions - physicochemical and spectroscopic analysis for antitubercular drugs. AAPS PharmSciTech. 2010;11(1):143-153.
Luki´ M, Panteli´ I, Savi´ SD. Towards optimal pH of the skin and topical formulations: from the current state of the art to tailored products. Cosmetics. 2021;8:69.
Parikh SK, Dave JB, Patel CN, Ramalingan B. Stability-indicating high-performance thin-layer chromatographic method for analysis of itraconazole in bulk drug and in pharmaceutical dosage form. Pharm Methods. 2011;2: 88-94.
Mali KK, Dhawale SC, Dias RJ. Microemulsion based bioadhesive gel of itraconazole using tamarind gum: in-vitro and ex-vivo evaluation. Marmara Pharm J. 2017; 21(3):688-700.
Shin JH, Choi KY, Kim YC, Lee MG. Dose-dependent phramacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect. Antimicrob Agents Chemother. 2004;48(5):1756-1762.
Špiclin P, Gašperlin M, Kmetec V. Stability of ascorbyl palmitate in topical microemulsions. Int J Pharm. 2001; 222(2):271-279.
Špiclin P, Homar M, Zupančič-Valant A, Gašperlin M. Sodium ascorbyl phosphate in topical microemulsions. Int J Pharm. 2003;256(1-2):65-73.
